Bicara Therapeutics Inc. (BCAX)
NASDAQ: BCAX · Real-Time Price · USD
26.87
+0.53 (2.01%)
At close: Jun 26, 2026, 4:00 PM EDT
26.87
0.00 (0.00%)
After-hours: Jun 26, 2026, 4:35 PM EDT
Bicara Therapeutics Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for Bicara Therapeutics stock have an average target of 32, with a low estimate of 16 and a high estimate of 46. The average target predicts an increase of 19.09% from the current stock price of 26.87.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Bicara Therapeutics stock from 15 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 8 | 8 | 9 | 9 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 2 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 13 | 14 | 14 | 15 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bank of America Securities | Bank of America Securities | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jun 2, 2026 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $16 → $18 | Hold | Maintains | $16 → $18 | -33.01% | Jun 2, 2026 |
| Wells Fargo | Wells Fargo | Hold Reiterates $25 → $16 | Hold | Reiterates | $25 → $16 | -40.45% | Jun 2, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $42 | Buy | Reiterates | $42 | +56.31% | Jun 1, 2026 |
Unknown Analyst Wedbush No rating | Wedbush | Buy Maintains $30 | Buy | Maintains | $30 | +11.65% | May 26, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-3.48
from -2.52
EPS Next Year
-3.63
from -3.48
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | n/a | n/a | |
| Avg | n/a | n/a | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2027 | 2028 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -2.52 | -2.68 | |
| Avg | -3.48 | -3.63 | |
| Low | -4.08 | -5.05 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.